Cargando…
Replacement of warfarin with a novel oral anticoagulant in endoscopic mucosal resection: a multicentre, open-label, randomised controlled trial
INTRODUCTION: This randomised controlled trial aims to compare the efficacy of warfarin replacement with apixaban without postoperative resumption of heparin with that of conventional heparin bridging in patients taking warfarin and scheduled to undergo endoscopic mucosal resection (EMR): specifical...
Autores principales: | Yamada, Takuya, Kada, Akiko, Uraoka, Toshio, Kuwai, Toshio, Watanabe, Noriko, Sasaki, Yoshihiro, Mabe, Katsuhiro, Takahashi, Yasuo, Kagaya, Takashi, Kimura, Toshihisa, Hamada, Hiroshige, Saito, Akiko M, Harada, Naohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623266/ https://www.ncbi.nlm.nih.gov/pubmed/29018538 http://dx.doi.org/10.1136/bmjgast-2017-000152 |
Ejemplares similares
-
Potential for replacing warfarin with a direct oral anticoagulant for endoscopic mucosal resection in the colorectum: A multicenter, open‐label, randomized controlled trial
por: Yamada, Takuya, et al.
Publicado: (2022) -
Haemostasis treatment using dual red imaging during endoscopic submucosal dissection: a multicentre, open-label, randomised controlled trial
por: Fujimoto, Ai, et al.
Publicado: (2019) -
Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study
por: Vanella, Giuseppe, et al.
Publicado: (2021) -
Therapeutic endoscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis
por: Nagata, Naoyoshi, et al.
Publicado: (2018) -
Treatment outcomes of endoscopic submucosal dissection and surgery for colorectal neoplasms in patients with ulcerative colitis
por: Kasuga, Kengo, et al.
Publicado: (2021)